Countries in the Eastern Mediterranean Region use genome sequencing to monitor COVID-19 variants

Cairo, 21 October 2021– In order to control a disease like COVID-19, scientist need to better understand the evolution of the virus, as well as how it mutates into different strains. Throughout the course of the pandemic, genome sequencing is vital in detecting, identifying, and understanding the evolution and genomic diversity of COVID-19. Genomic surveillance plays a key role in tracking transmission, developing vaccines, diagnostics, and therapeutics, as well as monitoring the mutation of the virus. To date, 14 out of 22 countries in WHO’s Region for the Eastern Mediterranean use genome sequencing to detect and monitor variants of concern circulating locally. The other eight countries are receiving support from WHO to sequence abroad. “As COVID-19 continues to evolve, the Regional response in the area of genome sequencing plays a key role on our efforts to better understand the virus. The progress made by countries since the start of the pandemic with the use of genome sequencing is significant but can still be strengthened and further expanded.” said Dr Ahmed Al-Mandhari, WHO Regional Director for the Eastern Mediterranean. “Not only will this help us learn more about the current virus and known strains, but also help us be better prepared to prevent and control future strains.” WHO’s Regional Office for the Eastern Mediterranean is working closely with governments to boost genomic surveillance capacity to track Read more...
Source: WHO EMRO News - Category: Middle East Health Source Type: news